Document is current

Any future updates will be listed below

CT‑based radiomics of bowel wall at baseline predicts the efficacy of Ustekinumab at week 16 in patients with Crohn’s disease

Crossref DOI link: https://doi.org/10.1007/s00261-025-05247-6

Published Online: 2025-11-24

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark